Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008

Completed · Not applicable

Conditions studied: Chronic Myeloid Leukemia

In brief

The objective of the study is to provide long term access to bosutinib treatment and assess long term safety, tolerability and duration of clinical benefit, without any formal hypothesis testing; therefore, there is no formal primary endpoint.

Key facts

Study ID

NCT01903733

Run by

Pfizer

People needed

281

Starts

2013-08-28

Expected to finish

2020-06-05

Last updated by the study team

2022-07-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Only subjects previously participating in two specific studies are eligible to enroll into this study. Enrollment is not open to subjects if not previously enrolled in studies B1871006 or B1871008.

You may not qualify if…

• All subjects are excluded unless previously participating in studies B1871006 or B1871008.

Where it is running

• Emory University Hospital — Atlanta, Georgia, United States
• The Emory Clinic — Atlanta, Georgia, United States
• Winship Cancer Institute, Emory University — Atlanta, Georgia, United States
• Northside Hospital Inc., - GCS/Northside — Atlanta, Georgia, United States
• Northside Hospital, Inc. - Central Research Department — Atlanta, Georgia, United States
• Indiana Blood and Marrow Transplantation — Indianapolis, Indiana, United States
• Siouxland Hematology-Oncology Associates, LLP — Sioux City, Iowa, United States
• Rcca Md,Llc — Bethesda, Maryland, United States
• Hudson Valley Hematology and Oncology Associates — Hawthorne, New York, United States
• Penn State Milton S. Hershey Medical Center — Hershey, Pennsylvania, United States
• The University of Texas MD Anderson Cancer Center — Houston, Texas, United States
• The University of Texas, MD Anderson Cancer Center — Houston, Texas, United States
• Instituto Medico Especializado Alexander Fleming — Cd. Autonoma de Buenos Aires, Buenos Aires, Argentina
• Hospital Italiano de la Plata — La Plata, Buenos Aires, Argentina
• Hospital Dr. Jose Ramon Vidal — Corrientes, Argentina
• Royal Brisbane & Women's Hospital — Herston, Queensland, Australia
• Royal Adelaide Hospital — Adelaide, South Australia, Australia
• GHDC (Grand Hopital de Charleroi) — Charleroi, Belgium
• Universidade Estadual de Campinas / Centro de Hematologia e Hemoterapia — Campinas, São Paulo, Brazil
• Faculdade de Medicina do ABC - Centro de Estudos e Pesquisa em Hematologia e Oncologia (CEPHO) — Santo André, São Paulo, Brazil
• Alberta Health Services - Department of Medical Oncology - Cross Cancer Institute — Edmonton, Alberta, Canada
• Vancouver General Hospital — Vancouver, British Columbia, Canada
• Princess Margaret Cancer Centre — Toronto, Ontario, Canada
• Sir Mortimer B. Davis-Jewish General Hospital — Montreal, Quebec, Canada
• Orlando Health, Inc — Orlando, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.